Literature DB >> 10447421

Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.

D Candotti1, D Costagliola, C Joberty, O Bonduelle, C Rouzioux, B Autran, H Agut.   

Abstract

Qualitative and quantitative virological parameters were investigated in 68 long-term nonprogressor (LTNP) HIV-1-infected patients and 9 slow-progressor controls. LTNP status was defined as an asymptomatic HIV infection for at least 8 years, a stability of CD4+ cell counts > or =600 cells/mm3 and no antiretroviral therapy. LTNP subjects exhibited a lower median plasma RNA load than controls (6,000 vs. 40,000 RNA copies/ ml) despite a wide range of values in both groups. When compared to the control group, LTNP subjects also exhibited a lower virus isolation rate (65% vs. 100%) and cell-associated viremia (0.75 vs. 56.8 number of infectious unit/ million cells) when CD8-depleted CD4+ cells were tested. By contrast, no major differences in virus replication properties or cell tropism were observed. After 1 year of follow-up, no major overall changes in the virological parameters was observed in the 50 LTNP subjects evaluated at this time. However, nine patients had started antiretroviral therapy, and six others had increased viral loads. Despite the progression observed during the first year of follow-up, the hypothesis that there is a specific subgroup of LTNP patients who will not develop disease cannot be ruled out as yet.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447421

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.

Authors:  Sara Ferrando-Martínez; Joseph P Casazza; Manuel Leal; Kawthar Machmach; Ma Ángeles Muñoz-Fernández; Pompeyo Viciana; Richard A Koup; Ezequiel Ruiz-Mateos
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.

Authors:  M Medina-Ramírez; V Sánchez-Merino; S Sánchez-Palomino; A Merino-Mansilla; C B Ferreira; I Pérez; N González; A Alvarez; J M Alcocer-González; F García; J M Gatell; J Alcamí; E Yuste
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

3.  Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Neil T Constantine; Dean L Mann; Manhattan Charurat; Elham Dadzan; Peter Kadlecik; Robert R Redfield
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

4.  Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.

Authors:  Simon J Potter; Christine Lacabaratz; Olivier Lambotte; Santiago Perez-Patrigeon; Benoît Vingert; Martine Sinet; Jean-Hervé Colle; Alejandra Urrutia; Daniel Scott-Algara; Faroudy Boufassa; Jean-François Delfraissy; Jacques Thèze; Alain Venet; Lisa A Chakrabarti
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

5.  Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.

Authors:  Karim Sacre; Guislaine Carcelain; Nathalie Cassoux; Anne-Marie Fillet; Dominique Costagliola; Daniel Vittecoq; Dominique Salmon; Zahir Amoura; Christine Katlama; Brigitte Autran
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

6.  Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.

Authors:  Olivier Lucar; Bin Su; Valérie Potard; Assia Samri; Brigitte Autran; Christiane Moog; Patrice Debré; Vincent Vieillard
Journal:  EBioMedicine       Date:  2017-07-11       Impact factor: 8.143

7.  Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Authors:  Assia Samri; Charlotte Charpentier; Mariama Sadjo Diallo; Mélanie Bertine; Sophie Even; Véronique Morin; Anne Oudin; Christophe Parizot; Gilles Collin; Anne Hosmalin; Rémi Cheynier; Rodolphe Thiébaut; Sophie Matheron; Fideline Collin; Rima Zoorob; Françoise Brun-Vézinet; Brigitte Autran
Journal:  PLoS Pathog       Date:  2019-05-16       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.